Partner with the Administration and Ranking Member Wyden to enact policies that realign incentives in the prescription drug supply chain, expand access to telehealth, and ensure long-term stability in the physician payment system.

Mike Crapo · Idaho · Republican

policy impact 0.74 specificity 0.89 extraction confidence 95%

Contest this claim

Occurrences

I remain committed to partnering with this Administration and Ranking Member Wyden to enact policies that realign incentives in the prescription drug supply chain, expand access to telehealth, and ensure long-term stability in our physician payment system.

Crapo commits to working with the Administration and Senator Wyden on health policy changes covering drug pricing incentives, telehealth access, and physician payment stability.

Crapo Statement at Hearing on the President’s 2026 Health Care Agenda | U.S. Senator Mike Crapo
primary · press_release · model gpt-5.4-mini

I remain committed to advancing [the targeted biosimilar access policy] ... I look forward to working together to move this policy through the Committee ... working to pursue its full Senate passage and enactment.

Commits to keep advancing bipartisan health-care legislation, including biosimilar access policy, through committee and toward Senate passage and enactment.

Crapo Statement at Bipartisan Health Care Policy Markup | U.S. Senator Mike Crapo
primary · press_release · model gpt-5.4-mini

Evidence

Senate Finance Committee Ranking Member Mike Crapo and Chair Ron Wyden released a bipartisan framework to pursue legislative solutions to modernize and enhance federal prescription drug programs. Crapo said he thanked Wyden for working with him to improve prescription drug access and affordability and said he looked forward to discussing consensus-based solutions with colleagues.

Official evidence that Crapo and Wyden began working together on prescription drug supply chain reforms, but this was a framework and not enactment.

partial same_term A for effort

Crapo, Wyden Release Legislative Framework to Address PBMs, Prescription Drug Supply Chain
secondary · model gpt-5.4-mini · confidence 95%

Contest this evidence item

The Finance Committee released a white paper outlining policy concepts related to reforming the way physicians are paid by Medicare and meeting the needs of those with chronic illness. The paper said the committee saw opportunities for reform including creating sustainable payment updates, improving primary care, supporting chronic care benefits, and ensuring continued access to telehealth.

Official evidence of concrete policy development on physician payment and telehealth, but only at the white-paper stage.

partial same_term A for effort

Wyden and Crapo Release White Paper for Medicare Doctor Pay Reform
secondary · model gpt-5.4-mini · confidence 93%

Contest this evidence item

The White House stated that the Working Families Tax Cuts Act signed into law on July 4, 2025 created the Rural Health Transformation Program and invested $50 billion over five years to transform rural health access.

Official evidence that a major health-care package became law, but this fact sheet is about rural health funding rather than specifically the prescription drug supply chain, telehealth, or physician payment stability.

partial same_term A for effort

Fact Sheet: President Donald J. Trump Celebrates the Great, Historic Investment in Rural Health
secondary · model gpt-5.4-mini · confidence 84%

Contest this evidence item

Crapo said the law makes health care more accessible and affordable and highlighted key wins including increased access to zero-deductible telehealth services. The release also said the Finance Committee provisions in the Working Families Tax Cuts Act expanded access to health savings accounts and made a transformational investment in rural health care systems.

Official evidence that telehealth access was expanded in enacted legislation associated with Crapo's Finance Committee work.

delivered same_term A for effort

Working Families Tax Cuts Improve Health Care Access and Affordability
secondary · model gpt-5.4-mini · confidence 90%

Contest this evidence item

Crapo said that working in partnership with Ranking Member Wyden, the Finance Committee delivered on its commitment to bring transparency and accountability to the prescription drug supply chain through pharmacy benefit manager reform. He said the bipartisan law would end perverse incentives for PBMs to steer patients toward higher-cost drugs and vertically integrated pharmacies.

Official evidence that the prescription drug supply chain portion was ultimately enacted as bipartisan law.

delivered same_term A for effort

Crapo Statement at Hearing on FY2027 HHS Budget
secondary · model gpt-5.4-mini · confidence 97%

Contest this evidence item

The Senate Finance Committee says Crapo and Wyden released a bipartisan framework to pursue legislative solutions on prescription drug programs, including lower drug costs, transparency, and changes to PBM incentives and pharmacy access.

Official evidence that Crapo actively partnered with Wyden on PBM and prescription drug supply-chain reforms, but at the framework stage rather than enactment.

partial same_term A for effort

Crapo, Wyden Release Legislative Framework to Address PBMs, Prescription Drug Supply Chain
secondary · model gpt-5.4-mini · confidence 96%

Contest this evidence item

Finance Committee leadership announced the Modernizing and Ensuring PBM Accountability Act, describing it as legislation to increase transparency, accountability, and competition in the pharmaceutical supply chain, and noting it reflected the committee's chairman's mark.

Official evidence that Crapo advanced concrete PBM legislation with Wyden, showing serious action on the prescription drug supply-chain portion of the promise.

partial same_term A for effort

Crapo, Wyden Introduce Finance Committee PBM Bill
secondary · model gpt-5.4-mini · confidence 94%

Contest this evidence item

The Finance Committee released a white paper on reforming Medicare physician payment and explicitly said one area of interest was ensuring continued access to telehealth, but it remained a policy paper rather than enacted law.

Official evidence of policy development on physician payment and telehealth, but not proof that long-term physician payment stabilization was enacted.

partial same_term A for effort

Wyden and Crapo Release White Paper for Medicare Doctor Pay Reform
secondary · model gpt-5.4-mini · confidence 95%

Contest this evidence item

Crapo stated that the enacted funding package included significant reforms from the Finance Committee's PBM package that would increase transparency in Medicare Part D and lower seniors' pharmacy costs, and that telehealth flexibilities were being extended.

Official evidence that parts of the prescription-drug and telehealth agenda were ultimately enacted or extended in later legislation.

delivered later_term A for effort

Crapo Applauds Bipartisan Finance Committee Priorities in Government Funding Bill
secondary · model gpt-5.4-mini · confidence 90%

Contest this evidence item

Crapo's committee statement says bipartisan health legislation had addressed prescription drug supply-chain issues and telehealth, but it does not show enactment of a long-term physician payment stabilization fix.

Official evidence that two major components were advanced or enacted, while the physician payment system component remained unresolved in the record reviewed.

partial later_term A for effort

Crapo Statement at Hearing on FY2027 HHS Budget
secondary · model gpt-5.4-mini · confidence 82%

Contest this evidence item

Assessments

partial same_term A for effort

Crapo materially advanced and obtained enactment of major pieces of the promise during his current Senate term: bipartisan PBM/prescription-drug supply-chain reforms and expanded or extended telehealth access were included in enacted legislation, with evidence tying those provisions to Finance Committee work with Wyden and the Administration. However, the promise also included ensuring long-term stability in the physician payment system, and the record shows only a white paper and policy development on Medicare doctor pay reform, not an enacted long-term stabilization fix. Because substantial components were delivered but one core component remains undelivered, the best classification is partial rather than delivered.

provider codex_cli · model gpt-5.5 · confidence 90%

partial same_term A for effort

The evidence supports enactment of prescription drug supply-chain/PBM reforms and some expansion of telehealth access during the same Senate term. However, the promise also required ensuring long-term stability in the physician payment system, and the provided evidence shows only a Finance Committee white paper and policy development on that component, not enacted long-term physician payment stabilization. Because major parts were delivered but one core promised outcome remains unfulfilled, the appropriate outcome is partial; Crapo made serious bipartisan legislative efforts, so the effort badge applies.

provider codex_cli · model gpt-5.5 · confidence 88%